Alamar Biosciences, Inc. (ALMR) Form 8-K Material Events
Alamar Biosciences, Inc. (ALMR) is a publicly traded company on the Nasdaq, categorized under SIC 3826 (Laboratory Analytical Instruments). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ALMR
CIK: 2104204
Exchange: Nasdaq
SIC 3826: Laboratory Analytical Instruments
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerKristen Pisani
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 144 | 2026-10-14 | — | 144 Filing | 0001231919-26-001458 | View SEC Doc Filr Page |
| 144 | 2026-10-14 | — | 144 Filing | 0001231919-26-001456 | View SEC Doc Filr Page |
| 144 | 2026-10-14 | — | 144 Filing | 0001231919-26-001455 | View SEC Doc Filr Page |
| 144 | 2026-10-14 | — | 144 Filing | 0001231919-26-001454 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | 4 Filing | 0001823381-26-000014 | View SEC Doc Filr Page |
| 3 | 2026-09-16 | 2026-09-14 | 3 Filing | 0001823381-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0001222644-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-09-03 | 2026-09-01 | 3 Filing | 0001222644-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-08-28 | 8-K | 0001193125-26-378360 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0002126941-26-000007 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-11 | — | SCHEDULE 13G Filing | 0002059127-26-000005 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-343003 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-342378 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-15 | 8-K | 0001193125-26-304736 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-07 | — | SCHEDULE 13D/A Filing | 0001875620-26-000010 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-02 | — | SCHEDULE 13G Filing | 0001862953-26-000003 | View SEC Doc Filr Page |
| 10-Q | 2026-05-08 | 2026-03-31 | 10-Q | 0001193125-26-213424 | View SEC Doc Filr Page |
| 8-K | 2026-05-08 | 2026-05-08 | 8-K | 0001193125-26-213379 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-04-23 | — | SCHEDULE 13D Filing | 0001193125-26-173780 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-04-23 | — | SCHEDULE 13D Filing | 0001875620-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-20 | 4 Filing | 0001231919-26-000392 | View SEC Doc Filr Page |
| EFFECT | 2026-04-20 | — | EFFECT Filing | 9999999995-26-001252 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | 4 | 0001193125-26-164634 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-20 | 4 Filing | 0001823563-26-000013 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-20 | 4 Filing | 0001455312-26-000004 | View SEC Doc Filr Page |